InMed Pharmaceuticals Inc. - Common Shares (INM) earnings

INM earnings moved a median of -2.18% by the close. Quarterly and annual INM reports and results, each read against the price at its own news timestamp. Back to the INM overview →

14 measured INM earnings events.

Where these INM earnings landedvs 14 measured INM earnings reactions
INM earningsMiddle 50% · -5.14% to -1.02%Zero: 0.00%Median: -2.18%Median -2.18%-8.00%0+8.00%
Middle 50% of INM earnings reactions-5.14% to -1.02%
Median reaction (to close)-2.18%
Measured reactions14
Point-in-time · zero look-ahead

Half of the 14 INM earnings events with a measured close landed between -5.14% and -1.02%; 14% closed up.

DateHeadlineEvent5-minTo close
Form 10-K InMed Pharmaceuticals For: Jun 30SEC filing · Form 10-K+0.00%+0.00%
Form 10-Q InMed Pharmaceuticals For: Mar 31SEC filing · Form 10-Q+0.00%-4.60%
Form 10-Q InMed Pharmaceuticals For: Dec 31SEC filing · Form 10-Q-4.96%-8.05%
Form 10-Q InMed Pharmaceuticals For: Sep 30SEC filing · Form 10-Q-0.27%-5.33%
Form 10-K/A InMed Pharmaceuticals For: Jun 30SEC filing · Form 10-K+0.49%-0.97%
Form 10-K InMed Pharmaceuticals For: Jun 30SEC filing · Form 10-K-0.14%-3.17%
Form 10-Q InMed Pharmaceuticals For: Mar 31SEC filing · Form 10-Q+2.78%+12.93%
Form 10-Q InMed Pharmaceuticals For: Dec 31SEC filing · Form 10-Q-0.63%-1.59%
Form 10-Q InMed Pharmaceuticals For: Sep 30SEC filing · Form 10-Q-0.41%-15.73%
Form 10-K InMed Pharmaceuticals For: Jun 30SEC filing · Form 10-K-5.08%-1.25%
Form 10-Q InMed Pharmaceuticals For: Mar 31SEC filing · Form 10-Q+0.00%-2.77%
Form 10-Q InMed Pharmaceuticals For: Dec 31SEC filing · Form 10-Q-5.39%-10.79%
Form 10-K/A InMed Pharmaceuticals For: Jun 30SEC filing · Form 10-K-4.33%+1.35%
Form 10-Q InMed Pharmaceuticals For: Sep 30SEC filing · Form 10-Q-1.15%-1.15%
That’s how INM usually reacts to earnings — get an email when it moves on news →
Keep exploring

More INM: analyst actions → · SEC filings → · INM overview →